Retinoblastoma | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

140 results for “Retinoblastoma”

Trials

View all 126 →

Not yet recruiting

Retinoblastoma Consolidation in Egyptians

150 participants · First posted Apr 15, 2026

Retinoblastoma Biomarker Study

2,136 participants · First posted Jun 21, 2006

Photoscreening for Retinoblastoma

76 participants · First posted Apr 14, 2020

Drugs

Cyclophosphamide(Procytox)

Manufacturer: Baxter healthcare corp, Baxter healthcare corp anesthesia and critical care +2 more

Conditions: Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukemia +21 more

C₇H₁₅Cl₂N₂O₂P

News

View all 13 →

Pig Semen-Derived Eye Drops Show Promise for Retinoblastoma Treatment in Preclinical Studies

Three Chemotherapy Cycles Non-Inferior to Six for High-Risk Retinoblastoma

VCN-01 Receives Orphan Drug Designation from European Commission for Retinoblastoma Treatment

Page 1 of 14